EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of PIPE-791 , A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders

Austin Chen iD, Christopher Baccei, Jill Baccei, Alexander Broadhead, Kym I Lorrain, Michael M Poon, Jeffrey Roppe, Thomas O Schrader iD, Karin J Stebbins, Lino Valdez, Yifeng Xiong, Daniel S Lorrain

Journal of Medicinal Chemistry · 09.07.2026 · 69 (13) · 15888-15927

DOI: 10.1021/acs.jmedchem.6c01049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 29.06.2026. Verfasst von Austin Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Contineum Therapeutics, 3565 General Atomics Court, Suite 200, San Diego, California 92121, United States. Hauptthemen laut MEDLINE: Brain, Neuroinflammatory Diseases, Receptors, Lysophosphatidic Acid, Urea. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Contineum Therapeutic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainNeuroinflammatory DiseasesReceptors, Lysophosphatidic AcidUreaAnimalsHumansMaleRatsBlood-Brain BarrierDrug DiscoveryRats, Sprague-DawleyStructure-Activity RelationshipSwineSwine, MiniatureRandomized Controlled Trials as TopicClinical Trials, Phase I as Topic

Substanzen

Receptors, Lysophosphatidic AcidUrea

Autor:innen und Institutionen

  • Contineum Therapeutics, 3565 General Atomics Court, Suite 200, San Diego, California 92121, United States.

ORCID-Profile: Austin Chen, Thomas O Schrader

Förderung

  • Contineum Therapeutic

Zitieren

APA

Chen, A., Baccei, C., Baccei, J., Broadhead, A., Lorrain, K. I., Poon, M. M., Roppe, J., Schrader, T. O., Stebbins, K. J., Valdez, L., Xiong, Y., & Lorrain, D. S. (2026). Discovery of PIPE-791 , A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders. Journal of Medicinal Chemistry, 69(13), 15888-15927. https://doi.org/10.1021/acs.jmedchem.6c01049

Vancouver

Chen A, Baccei C, Baccei J, Broadhead A, Lorrain KI, Poon MM, et al. Discovery of PIPE-791 , A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders. Journal of Medicinal Chemistry. 2026;69(13):15888-15927. doi:10.1021/acs.jmedchem.6c01049

BibTeX
@article{Chen2026,
  author = {Chen, Austin and Baccei, Christopher and Baccei, Jill and Broadhead, Alexander and Lorrain, Kym I and Poon, Michael M and Roppe, Jeffrey and Schrader, Thomas O and Stebbins, Karin J and Valdez, Lino and Xiong, Yifeng and Lorrain, Daniel S},
  title = {Discovery of PIPE-791 , A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {13},
  pages = {15888--15927},
  doi = {10.1021/acs.jmedchem.6c01049}
}
Kostenlos starten →